ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

About ASN

Patrick H. Nachman, MD, FASN, Councilor

ASN Biography

Patrick H. Nachman, MD, FASN, is a Professor of Medicine at the University of Minnesota School of Medicine, Director of the Division of Nephrology and Hypertension, Director of the Minnesota Multidisciplinary Vasculitis Program, and Medical Director of the Nephrology Service Line at M Health Fairview.

Dr. Nachman received his M.D. from Boston University School of Medicine, and completed an internal medicine residency, nephrology fellowship and postdoctoral research training at the University of North Carolina, Chapel Hill. He joined the faculty in the Division of Nephrology and Hypertension at UNC where he rose to become Professor of Medicine and the Marion Stedman Covington Distinguished Professor, and served as Deputy Director of the University of North Carolina Kidney Center.

His research efforts include the study of immune dysregulation leading to Antineutrophil Cytoplasmic Autoantibodies formation. Over the years his investigations have shifted from bench to the clinical and translational aspects of research in ANCA vasculitis as well as glomerular diseases. Dr. Nachman has focused on the clinical course, outcomes, and complications of vasculitis, FSGS and membranous nephropathy, and is committed to developing new therapies for patients with kidney disease, collaborating across disciplines and institutions, and postgraduate education.

Dr. Nachman has contributed to epidemiological studies, clinical trials, public/private partnerships in vasculitis, lupus nephritis, and several glomerular diseases and developed a personalized risk-benefit decision analysis tool for prophylactic anticoagulation in membranous nephropathy. He mentors young investigators at various stages of training in glomerular diseases and small vessel vasculitis.

Dr. Nachman serves as a member of the U.S. Food and Drug Administration Cardiovascular and Renal Drug Advisory Board and served as member of the Board of Directors of the Kidney Health Initiative. He also served as member of the UNC General Clinical Research Center Scientific Advisory Committee, and a member of the UNC Office of Human Research Ethics: Biomedical Institutional Review Board.

At the American Society of Nephrology, Dr. Nachman was Chair of the Postgraduate Education Committee, a member of the Education Committee, Co-Chair of the Glomerular Disease Early Program for ASN Kidney Week, a member of the Glomerular Disease Advisory Committee, the NephSAP Self-Assessment Program, the ASN KidneyCure Grant Review Committee, ASN Highlights and the ASN Board Review Course.